Note: Ingredients listed on restricted chemical lists
EC/CAS
247-722-4/26471-62-5
Name of the chemical
m-Tolylidendiisocyanat
Concentration
=1-<2,5
General Information
Version
1.0
Revision date
2025-02-25
Product name
Sikafloor M 869 Part B
1.2.1 Relevant identified uses
Polyurethane coating
supplier name
Sika Norge AS
Emergency telephone
22 59 13 00
Icons in SDS
Company Information
company name
Sika Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
kundeservice@no.sika.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breath- ing difficulties if inhaled.
Prevention
P261 Avoid breathing mist or vapours. P284 In case of inadequate ventilation wear respir- atory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Disposal
P501 Dispose of contents/container in accordance with local regulation.
Hazardous Ingredients
m-tolylidene diisocyanate
Additional information
"As from 24 August 2023 adequate training is required before industrial or pro- fessional use."
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have en- docrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regula- tion (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
